Clinical Trial Update: The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effectiveness and safety of intravesical docetaxel instillation to prevent bladder recurrence in urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Urothelial Carcinoma | Phase 2 | Status: UNKNOWN